|
SE0100567D0
(sv)
*
|
2001-02-20 |
2001-02-20 |
Astrazeneca Ab |
Compounds
|
|
AU2002364889A1
(en)
*
|
2001-09-24 |
2003-06-10 |
University Of Aarhus |
Methods for diagnosis and treatment of diseases associated with altered expression of nrf2
|
|
DE60215864T2
(de)
*
|
2001-11-30 |
2007-05-31 |
Qlt Inc., Vancouver |
Behandlung von okularen neovaskularen erkrankungen
|
|
AU2003211424A1
(en)
|
2002-03-01 |
2003-09-16 |
Yamanouchi Pharmaceutical Co., Ltd. |
Nitrogen-containing heterocyclic compound
|
|
AU2003255845A1
(en)
*
|
2002-08-22 |
2004-03-11 |
Piramed Limited |
Phosphadidylinositol 3,5-biphosphate inhibitors as anti-viral agents
|
|
EP1664037A1
(de)
*
|
2003-09-04 |
2006-06-07 |
Warner-Lambert Company Llc |
Halogensubstituierte benzo [b] thiophene mit pi3k-hemmender wirkung als therapeutische mittel
|
|
EP1709019B1
(de)
*
|
2004-01-12 |
2007-08-08 |
Applied Research Systems ARS Holding N.V. |
Thiazolderivate und deren verwendung
|
|
US20090209577A1
(en)
*
|
2004-08-18 |
2009-08-20 |
Pfizer Inc. |
Novel Triazolopyridine Compounds
|
|
GB0420722D0
(en)
|
2004-09-17 |
2004-10-20 |
Addex Pharmaceuticals Sa |
Novel allosteric modulators
|
|
RU2007119637A
(ru)
*
|
2004-10-28 |
2008-12-10 |
Айрм Ллк (Bm) |
Соединения и композиции в качестве модуляторов hedgehog-пути
|
|
WO2006049339A1
(ja)
|
2004-11-08 |
2006-05-11 |
Banyu Pharmaceutical Co., Ltd. |
新規縮環イミダゾール誘導体
|
|
US7723336B2
(en)
|
2005-09-22 |
2010-05-25 |
Bristol-Myers Squibb Company |
Fused heterocyclic compounds useful as kinase modulators
|
|
TWI417095B
(zh)
|
2006-03-15 |
2013-12-01 |
Janssen Pharmaceuticals Inc |
１，４-二取代之３-氰基-吡啶酮衍生物及其作為ｍＧｌｕＲ２-受體之正向異位性調節劑之用途
|
|
AU2007297754B2
(en)
*
|
2006-09-18 |
2012-05-17 |
Vertex Pharmaceuticals Incorporated |
Heterocyclic inhibitors of c-MET and uses thereof
|
|
RU2009120388A
(ru)
*
|
2006-10-30 |
2010-12-10 |
Новартис АГ (CH) |
Имидазопиридазины в качестве ингибиторов липидкиназы
|
|
EP1972631A1
(de)
*
|
2007-03-23 |
2008-09-24 |
Novartis AG |
Imidazopyridazine als PI3K-Lipidkinaseinhibitoren
|
|
CA2670636A1
(en)
|
2006-11-27 |
2008-06-05 |
H. Lundbeck A/S |
Heteroaryl amide derivatives
|
|
AR064106A1
(es)
*
|
2006-12-05 |
2009-03-11 |
Bayer Schering Pharma Ag |
Derivados de 2,3-dihidroimidazo [1,2-c] quinazolina sustituida utiles para el tratamiento de enfermedades y trastornos hiper-proliferativos asociados con la angiogenesis
|
|
CN101502484B
(zh)
*
|
2006-12-26 |
2011-04-20 |
济南康泉医药科技有限公司 |
同载糖皮质激素和化疗药物的抗癌缓释剂
|
|
TW200900065A
(en)
|
2007-03-07 |
2009-01-01 |
Janssen Pharmaceutica Nv |
3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
|
|
TW200845978A
(en)
|
2007-03-07 |
2008-12-01 |
Janssen Pharmaceutica Nv |
3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
|
|
PE20090188A1
(es)
|
2007-03-15 |
2009-03-20 |
Novartis Ag |
Compuestos heterociclicos como moduladores de la senda de hedgehog
|
|
EP2137184B1
(de)
|
2007-04-03 |
2013-05-08 |
Array Biopharma, Inc. |
Imidazo[1,2-a]pyridinverbindungen als rezeptortyrosinkinasehemmer
|
|
EA200970931A1
(ru)
|
2007-04-10 |
2010-04-30 |
Х. Лундбекк А/С |
Аналоги гетероариламидов
|
|
WO2008130951A1
(en)
*
|
2007-04-17 |
2008-10-30 |
Bristol-Myers Squibb Company |
Fused heterocyclic 11-beta-hydroxysteroid dehydrogenase type i inhibitors
|
|
MX2009012066A
(es)
*
|
2007-05-09 |
2009-11-19 |
Novartis Ag |
Imidazopirinas sustituidas como inhibidoras de cinasa de lipido p13k.
|
|
CN101765596B
(zh)
*
|
2007-05-18 |
2015-04-29 |
拜耳知识产权有限责任公司 |
用于治疗过增生症状和与血管生成有关疾病的缺氧诱导因子(hif)抑制剂
|
|
EP2062893A1
(de)
*
|
2007-10-18 |
2009-05-27 |
Bayer Schering Pharma AG |
Fusionierte Imidazole zur Behandlung von Krebs
|
|
JP5327652B2
(ja)
*
|
2007-08-14 |
2013-10-30 |
バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング |
癌処理のための融合されたイミダゾール
|
|
PT2200985E
(pt)
|
2007-09-14 |
2011-07-21 |
Ortho Mcneil Janssen Pharm |
4-(aril-x-fenil)-1h-piridin-2-onas 1,3-dissubstituídas
|
|
UA100126C2
(en)
|
2007-09-14 |
2012-11-26 |
Аддекс Фарма С.А. |
1',3'-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2h, 1'h-[1, 4'] bipyridinyl-2'-ones
|
|
EP2060565A1
(de)
|
2007-11-16 |
2009-05-20 |
4Sc Ag |
Neue bifunktionelle Verbindungen die Proteinkinasen und Histonedeacetylasen hemmen
|
|
CA2706578A1
(en)
*
|
2007-11-27 |
2009-06-04 |
Cellzome Limited |
Amino triazoles as pi3k inhibitors
|
|
CN101981033B
(zh)
|
2008-02-06 |
2015-02-04 |
百时美施贵宝公司 |
用作激酶抑制剂的取代的咪唑并哒嗪化合物
|
|
WO2009106577A1
(en)
|
2008-02-28 |
2009-09-03 |
Novartis Ag |
Imidazo [1,2-b] pyridazine derivatives for the treatment of c-met tyrosine kinase mediated disease
|
|
WO2009126861A2
(en)
|
2008-04-11 |
2009-10-15 |
Bristol-Myers Squibb Company |
Triazolopyridine compounds useful as dgat1 inhibitors
|
|
US8324241B2
(en)
|
2008-04-11 |
2012-12-04 |
Bristol-Myers Squibb Company |
Triazolo compounds useful as DGAT1 inhibitors
|
|
WO2010009139A2
(en)
|
2008-07-14 |
2010-01-21 |
Gilead Colorado, Inc. |
Imidazolyl pyrimidine inhibitor compounds
|
|
WO2010009166A1
(en)
|
2008-07-14 |
2010-01-21 |
Gilead Colorado, Inc. |
Oxindolyl inhibitor compounds
|
|
NZ602832A
(en)
|
2008-07-14 |
2014-04-30 |
Gilead Sciences Inc |
Fused heterocyclic hdac inhibitor compounds
|
|
WO2010007099A1
(en)
*
|
2008-07-15 |
2010-01-21 |
Cellzome Limited |
2-aminoimidazo[1,2-b]pyridazine derivatives as pi3k inhibitors
|
|
US20100041663A1
(en)
|
2008-07-18 |
2010-02-18 |
Novartis Ag |
Organic Compounds as Smo Inhibitors
|
|
AU2009276699A1
(en)
|
2008-07-28 |
2010-02-04 |
Gilead Sciences, Inc. |
Cycloalkylidene and heterocycloalkylidene histone deacetylase inhibitor compounds
|
|
US8895550B2
(en)
|
2008-08-19 |
2014-11-25 |
Array Biopharma Inc. |
Triazolopyridine compounds as PIM kinase inhibitors
|
|
US8557809B2
(en)
|
2008-08-19 |
2013-10-15 |
Array Biopharma Inc. |
Triazolopyridine compounds as PIM kinase inhibitors
|
|
US8987251B2
(en)
|
2008-08-19 |
2015-03-24 |
Array Biopharma Inc. |
Triazolopyridine compounds as PIM kinase inhibitors
|
|
TWI496779B
(zh)
|
2008-08-19 |
2015-08-21 |
Array Biopharma Inc |
作為ｐｉｍ激酶抑制劑之三唑吡啶化合物
|
|
AU2009289784B2
(en)
|
2008-09-02 |
2012-03-22 |
Addex Pharma S.A. |
3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors
|
|
TWI491610B
(zh)
|
2008-10-09 |
2015-07-11 |
必治妥美雅史谷比公司 |
作為激酶抑制劑之咪唑并嗒腈
|
|
BRPI0921333A2
(pt)
|
2008-11-28 |
2015-12-29 |
Addex Pharmaceuticals Sa |
derivados de indol e benzoxazina como moduladores de receptores de glutamato metabotrópicos
|
|
WO2010074586A1
(en)
*
|
2008-12-23 |
2010-07-01 |
Pathway Therapeutics Limited |
Pyrazolo[1,5-a]pyridine and imidazo[1,2-a]pyridine derivatives and their use in cancer therapy
|
|
EP2417135A1
(de)
|
2009-04-07 |
2012-02-15 |
Schering Corporation |
Substituierte triazolopyridine und analoga davon
|
|
BRPI1010831A2
(pt)
|
2009-05-12 |
2016-04-05 |
Addex Pharmaceuticals Sa |
derivados de 1,2,4-triazolo[4,3-a]piridina e seu como moduladores alostéricos positivos de receptores de mglur2
|
|
MY153913A
(en)
|
2009-05-12 |
2015-04-15 |
Janssen Pharmaceuticals Inc |
7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
|
|
KR101753826B1
(ko)
|
2009-05-12 |
2017-07-04 |
얀센 파마슈티칼즈, 인코포레이티드 |
1,２,４―트리아졸로［４,３―ａ］피리딘 유도체 및 신경정신 질환의 치료 또는 예방을 위한 이들의 용도
|
|
JP2012529514A
(ja)
|
2009-06-08 |
2012-11-22 |
ギリアード サイエンシーズ， インコーポレイテッド |
シクロアルキルカルバメートベンズアミドアニリンｈｄａｃ阻害剤化合物
|
|
MX2011013165A
(es)
|
2009-06-08 |
2012-01-30 |
Gilead Sciences Inc |
Compuestos inhibidores de hdac de alcanoilamino-benzamida-anilina.
|
|
US8389526B2
(en)
|
2009-08-07 |
2013-03-05 |
Novartis Ag |
3-heteroarylmethyl-imidazo[1,2-b]pyridazin-6-yl derivatives
|
|
MX2012001838A
(es)
|
2009-08-12 |
2012-02-29 |
Novartis Ag |
Compuestos de hidrazona heterociclico y sus usos para tratar cancer e inflamacion.
|
|
IN2012DN01453A
(de)
|
2009-08-20 |
2015-06-05 |
Novartis Ag |
|
|
EP2496578A4
(de)
|
2009-11-05 |
2013-08-21 |
Univ Notre Dame Du Lac |
Imidazo[1,2-a]pyridin-verbindungen, ihre synthese und verfahren zu ihrer verwendung
|
|
JP2013510137A
(ja)
*
|
2009-11-06 |
2013-03-21 |
ピラマル・ライフ・サイエンシーズ・リミテッド |
イミダゾピリジン誘導体
|
|
JP5774602B2
(ja)
*
|
2009-12-30 |
2015-09-09 |
アークル インコーポレイテッド |
置換されたイミダゾピリジニル−アミノピリジン化合物
|
|
CN102971326A
(zh)
|
2010-04-28 |
2013-03-13 |
百时美施贵宝公司 |
咪唑并哒嗪化合物及其在癌症中的用途
|
|
TWI541243B
(zh)
|
2010-09-10 |
2016-07-11 |
拜耳知識產權公司 |
經取代咪唑并嗒
|
|
AU2011328203B2
(en)
|
2010-11-08 |
2015-03-19 |
Janssen Pharmaceuticals, Inc. |
1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors
|
|
ES2536433T3
(es)
|
2010-11-08 |
2015-05-25 |
Janssen Pharmaceuticals, Inc. |
Derivados de 1,2,4-triazolo[4,3-a]piridina y su uso como moduladores alostéricos positivos de receptores mGluR2
|
|
EP2649069B1
(de)
|
2010-11-08 |
2015-08-26 |
Janssen Pharmaceuticals, Inc. |
1,2,4-triazol[4,3-a]pyridinderivate und ihre verwendung als positive allosterische mglur2-rezeptormodulatoren
|
|
WO2012068204A1
(en)
*
|
2010-11-18 |
2012-05-24 |
Janssen Pharmaceutica Nv |
Fused heteroaryl inhibitors of pro-matrix metalloproteinase activation
|
|
WO2012087833A1
(en)
|
2010-12-22 |
2012-06-28 |
Abbott Laboratories |
Hepatitis c inhibitors and uses thereof
|
|
CN102030752A
(zh)
*
|
2011-01-06 |
2011-04-27 |
贵阳中医学院 |
一种制备化合物2-(咪唑并[1,2-a]吡啶-3-基)乙腈的方法
|
|
US9000186B2
(en)
|
2011-02-01 |
2015-04-07 |
Kyowa Hakko Kirin Co., Ltd. |
Ring-fused heterocyclic derivative
|
|
EP2678329B1
(de)
|
2011-02-25 |
2015-11-18 |
Array Biopharma Inc. |
Triazolopyridin verbindungen als pim kinase hemmer
|
|
ME02316B
(me)
|
2011-04-07 |
2016-06-20 |
Bayer Ip Gmbh |
Imidazopiridazini kao inhibitori akt kinaze
|
|
WO2012156379A1
(en)
*
|
2011-05-13 |
2012-11-22 |
Universität Zürich |
PIK3/P110α INHIBITORS FOR PREVENTION OF RESTENOSIS BY APPLICATION AS AN IMPLANT COATING
|
|
KR101274986B1
(ko)
*
|
2011-07-27 |
2013-06-17 |
한국과학기술원 |
이미다조피리딘 유도체, 이를 포함하는 ＰＩ3Ｋ 및/또는 ｍＴＯＲ 저해제용 약학 조성물 및 ＰＩ3Ｋ 및/또는 ｍＴＯＲ과 연관된 질환 치료용 약학 조성물
|
|
TW201410677A
(zh)
|
2012-07-31 |
2014-03-16 |
Kyowa Hakko Kirin Co Ltd |
縮環雜環化合物
|
|
US8796305B2
(en)
|
2012-11-05 |
2014-08-05 |
Bayer Pharma Aktiengesellschaft |
Carboxy-substituted imidazo[1,2-a]pyridinecarboxamides and their use
|
|
US9624214B2
(en)
|
2012-11-05 |
2017-04-18 |
Bayer Pharma Aktiengesellschaft |
Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their use
|
|
US8778964B2
(en)
|
2012-11-05 |
2014-07-15 |
Bayer Pharma Aktiengesellschaft |
Hydroxy-substituted imidazo[1,2-a]-pyridinecarboxamides and their use
|
|
US9126998B2
(en)
|
2012-11-05 |
2015-09-08 |
Bayer Pharma AG |
Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their use
|
|
JP6056872B2
(ja)
*
|
2012-11-30 |
2017-01-11 |
アステラス製薬株式会社 |
イミダゾピリジン化合物
|
|
MX2015010714A
(es)
|
2013-02-19 |
2016-06-14 |
Pfizer |
Compuestos de azabencimidazol.
|
|
CN105339368B
(zh)
|
2013-06-04 |
2017-08-15 |
拜耳制药股份公司 |
3‑芳基‑取代的咪唑并[1,2‑a]吡啶及其用途
|
|
JO3368B1
(ar)
|
2013-06-04 |
2019-03-13 |
Janssen Pharmaceutica Nv |
مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
|
|
JO3367B1
(ar)
|
2013-09-06 |
2019-03-13 |
Janssen Pharmaceutica Nv |
مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2
|
|
HUE045610T2
(hu)
|
2014-01-21 |
2020-01-28 |
Janssen Pharmaceutica Nv |
2-es altípusú metabotróp glutamáterg receptor pozitív allosztérikus modulátorait vagy ortosztérikus agonistáit tartalmazó kombinációk és alkalmazásuk
|
|
MX2016009471A
(es)
|
2014-01-21 |
2016-10-13 |
Janssen Pharmaceutica Nv |
Combinaciones que comprenden agonistas ortostericos o moduladores alostericos positivos del receptor glutamatergico metabotropico de subtipo 2 y su uso.
|
|
US9493442B2
(en)
|
2014-02-13 |
2016-11-15 |
Incyte Corporation |
Cyclopropylamines as LSD1 inhibitors
|
|
US9527835B2
(en)
|
2014-02-13 |
2016-12-27 |
Incyte Corporation |
Cyclopropylamines as LSD1 inhibitors
|
|
CR20200199A
(es)
|
2014-02-13 |
2020-06-19 |
Incyte Corp |
CICLOPROPILAMINA COMO INHIBIDOR DE LA LSD1 (Divisional 2016-0396)
|
|
EP3105226B1
(de)
|
2014-02-13 |
2019-09-04 |
Incyte Corporation |
Cyclopropylamine als lsd1-hemmer
|
|
JP2017507140A
(ja)
|
2014-02-19 |
2017-03-16 |
バイエル・ファルマ・アクティエンゲゼルシャフト |
３−（ピリミジン−２−イル）イミダゾ［１，２−ａ］ピリジン
|
|
JP2017508810A
(ja)
|
2014-03-21 |
2017-03-30 |
バイエル・ファルマ・アクティエンゲゼルシャフト |
シアノ置換イミダゾ［１，２−ａ］ピリジンカルボキサミドおよびその使用
|
|
JP6578298B2
(ja)
*
|
2014-03-24 |
2019-09-18 |
アークル インコーポレイテッド |
３−（３−（４−（１−アミノシクロブチル）フェニル）−５−フェニル−３ｈ−イミダゾ［４，５−ｂ］ピリジン−２−イル）ピリジン−２−アミンを調製する方法
|
|
HUE046150T2
(hu)
*
|
2014-04-22 |
2020-02-28 |
Arqule Inc |
Helyettesített imidazopiridinil-amino-piridin vegyületek sói és polimorf formái
|
|
JP2017514898A
(ja)
|
2014-05-02 |
2017-06-08 |
バイエル・ファルマ・アクティエンゲゼルシャフト |
心血管疾患の治療のためのｎ−（２−アミノ−５−フルオロ−２−メチルペンチル）−８−［（２，６−ジフルオロベンジル）オキシ］−２−メチルイミダゾ［１，２−ａ］ピリジン−３−カルボキサミドの、並びにジ−及びトリフルオロ誘導体のエナンチオマー
|
|
WO2016007736A1
(en)
|
2014-07-10 |
2016-01-14 |
Incyte Corporation |
Imidazopyrazines as lsd1 inhibitors
|
|
WO2016007722A1
(en)
|
2014-07-10 |
2016-01-14 |
Incyte Corporation |
Triazolopyridines and triazolopyrazines as lsd1 inhibitors
|
|
WO2016007727A1
(en)
|
2014-07-10 |
2016-01-14 |
Incyte Corporation |
Triazolopyridines and triazolopyrazines as lsd1 inhibitors
|
|
WO2016007731A1
(en)
|
2014-07-10 |
2016-01-14 |
Incyte Corporation |
Imidazopyridines and imidazopyrazines as lsd1 inhibitors
|
|
JP6713982B2
(ja)
|
2014-07-24 |
2020-06-24 |
ファイザー・インク |
ピラゾロピリミジン化合物
|
|
MX2017001565A
(es)
|
2014-08-06 |
2017-04-27 |
Pfizer |
Compuestos de imidazopiridazina.
|
|
JP2017536396A
(ja)
|
2014-12-02 |
2017-12-07 |
バイエル・ファルマ・アクティエンゲゼルシャフト |
ヘテロアリール置換イミダゾ［１，２−ａ］ピリジンおよびその使用
|
|
AU2016243939B2
(en)
|
2015-04-03 |
2020-09-03 |
Incyte Holdings Corporation |
Heterocyclic compounds as LSD1 inhibitors
|
|
TWI765860B
(zh)
|
2015-08-12 |
2022-06-01 |
美商英塞特公司 |
Lsd1抑制劑之鹽
|
|
WO2017049321A1
(en)
|
2015-09-17 |
2017-03-23 |
Miller Marvin J |
Benzyl amine-containing heterocyclic compounds and compositions useful against mycobacterial infection
|
|
GB201602527D0
(en)
*
|
2016-02-12 |
2016-03-30 |
Glaxosmithkline Ip Dev Ltd |
Chemical compounds
|
|
WO2017181973A1
(zh)
*
|
2016-04-20 |
2017-10-26 |
苏州苏领生物医药有限公司 |
五元杂环类化合物及其制备方法、药物组合物和用途
|
|
CN107304202A
(zh)
*
|
2016-04-20 |
2017-10-31 |
苏州苏领生物医药有限公司 |
五元杂环类化合物及其制备方法、药物组合物和用途
|
|
JP6999574B2
(ja)
|
2016-04-22 |
2022-01-18 |
インサイト・コーポレイション |
Ｌｓｄ１阻害剤の製剤
|
|
WO2017197151A1
(en)
|
2016-05-11 |
2017-11-16 |
Emory University |
Phosphotidylinositol 3-kinase inhibitors
|
|
WO2018013430A2
(en)
|
2016-07-12 |
2018-01-18 |
Arisan Therapeutics Inc. |
Heterocyclic compounds for the treatment of arenavirus infection
|
|
WO2018184976A1
(de)
|
2017-04-05 |
2018-10-11 |
Bayer Pharma Aktiengesellschaft |
Substituierte imidazo[1,2-a]pyridincarboxamide und ihre verwendung
|
|
MA50440A
(fr)
|
2017-10-24 |
2020-09-02 |
Bayer Ag |
Imidazopyridinamides substituées et leur utilisation
|
|
US10968200B2
(en)
|
2018-08-31 |
2021-04-06 |
Incyte Corporation |
Salts of an LSD1 inhibitor and processes for preparing the same
|
|
SG11202109786UA
(en)
|
2019-03-19 |
2021-10-28 |
Boehringer Ingelheim Animal Health Usa Inc |
Anthelmintic aza-benzothiophene and aza-benzofuran compounds
|
|
WO2020216669A1
(de)
|
2019-04-23 |
2020-10-29 |
Bayer Aktiengesellschaft |
Phenylsubstituierte imidazopyridinamide und ihre verwendung
|
|
KR20220161420A
(ko)
*
|
2020-04-27 |
2022-12-06 |
주식회사 오토텍바이오 |
Ubr 박스 도메인 리간드로의 화합물
|
|
WO2021242581A1
(en)
|
2020-05-29 |
2021-12-02 |
Boehringer Ingelheim Animal Health USA Inc. |
Anthelmintic heterocyclic compounds
|
|
CN113135913B
(zh)
*
|
2021-04-28 |
2022-05-24 |
沈阳药科大学 |
3-取代基-6-吡啶类取代基-六元并五元杂环类衍生物及其制法与用途
|
|
CA3236894A1
(en)
|
2021-11-01 |
2023-05-04 |
Boehringer Ingelheim Vetmedica Gmbh |
Anthelmintic pyrrolopyridazine compounds
|